Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program

巴布森生命科学创业产品开发沉浸式新技术和解决方案 (Babson L-SPRINT) 计划

• 批准号: 10678869
• 负责人: Wiljeana Glover
• 金额: $ 31.62万
• 依托单位: BABSON COLLEGE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2027-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10678869
• 关键词: Active Learning; Address; Basic Science; Biological Sciences; Businesses; Communities; Coupled; Decision Making; Development; Devices; Diagnostic Equipment; Drug Addiction; Economic Development; Education; Educational Curriculum; Electronic Mail; Emerging Technologies; Entrepreneurship; Environment; Faculty; Future; Goals; Growth; Health; Healthcare; Immersion; Individual; Industry; Intellectual Property; Marketing; Mechanics; Mobile Health Application; National Institute of Drug Abuse; Neurosciences; Newsletter; Organizational Culture; Outcome; Participant; Patient Recruitments; Personal Satisfaction; Pharmaceutical Preparations; Public Health; Research; Research Personnel; Rewards; Role; Scientist; Structure; Substance Use Disorder; Techniques; Technology; Therapeutic; Thinking; Training; Uncertainty; United States; United States National Institutes of Health; Work; college; commercialization; community building; curriculum development; experience; improved; innovation; interest; new technology; organizational structure; outreach; product development; programs; recruit; skill acquisition; substance use treatment; symposium; tool

PROJECT SUMMARY Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program Commercialized innovations and new ventures that address certain conditions, including ventures that address the causes, consequences, and treatment of substance use disorders (SUDs) to improve individual and public health, are still underrepresented amongst recent startups. Commercialization and technology-based start-ups can be challenging in an academic environment due to varying reward structures, organizational structures and organizational cultures. Many promising scientists are reluctant to pursue intellectual property (IP) protection and investigate commercialization opportunities, even for unique research findings, due to a lack of understanding of the mechanics towards productizing and commercialization. To address these misperceptions and challenges while amplifying the potential impact that academic scientists can make to address SUDs, the Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program will reach scientists interested in product development and commercialization as well as to train participants in entrepreneurial thinking that can also increase decision making, improve their organizations and labs from within, especially since product development in the biomedical industry is highly uncertain. The Babson L-SPRINT Program includes two aims: Aim 1: Curriculum Development--The Babson L-SPRINT program will develop a specialized curriculum highlighting Babson’s signature Entrepreneurial Thought & Action ® offering coupled with customized healthcare and biomedical entrepreneurship content on addressing market segmentation and uncertainty, commercializing emerging technologies, scaling for growth, and biomedical community experiences. The program will use live cases, panels, and other experiential learning techniques. Aim 2: Courses for Skills Development--We will also develop a recruitment and outreach strategy using an innovative omnichannel approach including direct marketing utilizing email, relevant conferences, and via NIH NIDA newsletters and other media as available.

项目总结